Literature DB >> 338314

The role of the corpus striatum in neuroleptic- and narcotic-induced catalepsy.

K B Koffer, S Berney, O Hornykiewicz.   

Abstract

Lesion experiments (in the rat) were designed to elucidate the function of the corpus striatum in neuroleptic- and narcotic-induced catalepsy, respectively. Bilateral lesions of the corpus striatum were observed to attenuate neuroleptic (CPZ)-induced catalepsy. However, analogous lesions of the corpus striatum potentiated narcotic (morphine)-induced catalepsy. These results suggests that (a) the corpus striatum may be a primary site of action of neuroleptic drugs (such as CPZ) in the production of catalepsy, and (b) narcotic (morphine)-induced catalepsy may not be exclusively mediated by the corpus striatum.

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 338314     DOI： 10.1016/0014-2999(78)90377-1

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN： 0014-2999            Impact factor:   4.432


  11 in total

1.  Conditional tolerance to haloperidol-induced catalepsy is not caused by striatal dopamine receptor supersensitivity.

Authors:  C J de Graaf; J Korf
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

Review 2.  Role of nitric oxide on motor behavior.

Authors:  E A Del Bel; F S Guimarães; M Bermúdez-Echeverry; M Z Gomes; A Schiaveto-de-souza; F E Padovan-Neto; V Tumas; A P Barion-Cavalcanti; M Lazzarini; L P Nucci-da-Silva; D de Paula-Souza
Journal:  Cell Mol Neurobiol       Date:  2005-03       Impact factor: 5.046

3.  An e.c.g. vector simulator to facilitate learning of the basic principles of electrocardiography [proceedings].

Authors:  F Johnson; G V Sawle; D R Tomlinson
Journal:  J Physiol       Date:  1980-01       Impact factor: 5.182

4.  Combined treatment of ascorbic acid or alpha-tocopherol with dopamine receptor antagonist or nitric oxide synthase inhibitor potentiates cataleptic effect in mice.

Authors:  M Lazzarini; C Salum; E A Del Bel
Journal:  Psychopharmacology (Berl)       Date:  2005-10-15       Impact factor: 4.530

Review 5.  Dopamine receptor agonists: mechanisms underlying autoreceptor selectivity. II. Theoretical considerations.

Authors:  D Clark; S Hjorth; A Carlsson
Journal:  J Neural Transm       Date:  1985       Impact factor: 3.575

6.  The striatal dopaminergic catalepsy mechanism is not necessary for the expression of pontine catalepsy produced by carbachol injections into the pontine reticular formation.

Authors:  Z Elazar; N Peleg; M Paz; G Ring
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-08       Impact factor: 3.000

7.  Central dopamine receptor agonist and antagonist actions of the enantiomers of 3-PPP.

Authors:  S Hjorth; A Carlsson; D Clark; K Svensson; H Wikström; D Sanchez; P Lindberg; U Hacksell; L E Arvidsson; A Johansson
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

8.  Cholinergic-dopaminergic interactions in experimental catalepsy.

Authors:  W R Klemm
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

9.  Haloperidol-induced emotional defecation: a possible model for neuroleptic anxiety syndrome.

Authors:  K H Russell; S H Hagenmeyer-Houser; P R Sanberg
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

10.  Effects of typical and atypical antipsychotic drugs on two-way active avoidance. Relationship to DA receptor blocking profile.

Authors:  S O Ogren; T Archer
Journal:  Psychopharmacology (Berl)       Date:  1994-04       Impact factor: 4.530
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.